Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Utility of Growth Differentiation Factor-15, A Marker of Oxidative Stress and Inflammation, in Chronic Heart Failure
Abhinav Sharma, Susanna R. Stevens, Joseph Lucas, et al.
JACC Heart Failure (2017) Vol. 5, Iss. 10, pp. 724-734
Open Access | Times Cited: 86

Showing 1-25 of 86 citing articles:

Identifying Pathophysiological Mechanisms in Heart Failure With Reduced Versus Preserved Ejection Fraction
Jasper Tromp, B. Daan Westenbrink, Wouter Ouwerkerk, et al.
Journal of the American College of Cardiology (2018) Vol. 72, Iss. 10, pp. 1081-1090
Open Access | Times Cited: 252
Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies
Alberto Aimo, Vincenzo Castiglione, Chiara Borrelli, et al.
European Journal of Preventive Cardiology (2019) Vol. 27, Iss. 5, pp. 494-510
Closed Access | Times Cited: 238
Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association (HFA), European Society of Cardiology (ESC)
Wouter C. Meijers, Antoni Bayés‐Genís, Alexandre Mebazaa, et al.
European Journal of Heart Failure (2021) Vol. 23, Iss. 10, pp. 1610-1632
Open Access | Times Cited: 115
Inflammation in heart failure: pathophysiology and therapeutic strategies
Jacinthe Boulet, Vikas S. Sridhar, Nadia Bouabdallaoui, et al.
Inflammation Research (2024) Vol. 73, Iss. 5, pp. 709-723
Open Access | Times Cited: 19
Performance of the ABC Scores for Assessing the Risk of Stroke or Systemic Embolism and Bleeding in Patients With Atrial Fibrillation in ENGAGE AF-TIMI 48
David D. Berg, Christian T. Ruff, Petr Jarolı́m, et al.
Circulation (2019) Vol. 139, Iss. 6, pp. 760-771
Open Access | Times Cited: 123
Biomarkers in heart failure: the past, current and future
Sarhene Michael, Yili Wang, Jing Wei, et al.
Heart Failure Reviews (2019) Vol. 24, Iss. 6, pp. 867-903
Closed Access | Times Cited: 110
Biomarkers for heart failure: small molecules with high clinical relevance
Christina Magnussen, Stefan Blankenberg
Journal of Internal Medicine (2018) Vol. 283, Iss. 6, pp. 530-543
Open Access | Times Cited: 109
Advances in heart failure monitoring: Biosensors targeting molecular markers in peripheral bio-fluids
Tao Dong, Wangang Zhu, Zhaochu Yang, et al.
Biosensors and Bioelectronics (2024) Vol. 255, pp. 116090-116090
Closed Access | Times Cited: 10
Current and novel biomarkers in cardiogenic shock
Victor Galusko, Florian A. Wenzl, Christophe Vandenbriele, et al.
European Journal of Heart Failure (2025)
Open Access | Times Cited: 1
Growth differentiation factor‐15 is not modified by sacubitril/valsartan and is an independent marker of risk in patients with heart failure and reduced ejection fraction: the PARADIGM‐HF trial
Nadia Bouabdallaoui, Brian Claggett, Michael R. Zile, et al.
European Journal of Heart Failure (2018) Vol. 20, Iss. 12, pp. 1701-1709
Open Access | Times Cited: 73
The Use of Biomarkers in Clinical Management Guidelines: A Critical Appraisal
María Asunción Esteve‐Pastor, Vanessa Roldán, José Miguel Rivera‐Caravaca, et al.
Thrombosis and Haemostasis (2019) Vol. 119, Iss. 12, pp. 1901-1919
Open Access | Times Cited: 69
Diagnosis and Management of Malnutrition in Patients with Heart Failure
Alberto Esteban‐Fernández, Rocío Villar-Taibo, Mirian Alejo Ramos, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 9, pp. 3320-3320
Open Access | Times Cited: 20
CircLPAR1 Promotes Neuroinflammation and Oxidative Stress in APP/PS1 Mice by Inhibiting SIRT1/Nrf-2/HO-1 Axis Through Destabilizing GDF-15 mRNA
Wenping Xiong, Dongming Li, Yu Feng, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 4, pp. 2236-2251
Closed Access | Times Cited: 19
The clinical impact of growth differentiation factor-15 in heart disease: A 2019 update
Maria Arkoumani, Nektaria Papadopoulou‐Marketou, Nicolas C. Nicolaides, et al.
Critical Reviews in Clinical Laboratory Sciences (2019) Vol. 57, Iss. 2, pp. 114-125
Closed Access | Times Cited: 48
Identification of novel diagnostic and prognostic biomarkers for abdominal aortic aneurysm
Ashfaque A. Memon, Moncef Zarrouk, Sophia Ågren-Witteschus, et al.
European Journal of Preventive Cardiology (2019) Vol. 27, Iss. 2, pp. 132-142
Closed Access | Times Cited: 47
The utility of growth differentiation factor-15, galectin-3, and sST2 as biomarkers for the diagnosis of heart failure with preserved ejection fraction and compared to heart failure with reduced ejection fraction: a systematic review
Simon W. Rabkin, Jacky K. K. Tang
Heart Failure Reviews (2020) Vol. 26, Iss. 4, pp. 799-812
Closed Access | Times Cited: 42
GDF-15 como Biomarcador em Doenças Cardiovasculares
Bruna Miers May, Maurício Pimentel, Leandro Ioschpe Zimerman, et al.
Arquivos Brasileiros de Cardiologia (2021)
Open Access | Times Cited: 35
Growth differentiation factor-15, a novel systemic biomarker of oxidative stress, inflammation, and cellular aging: Potential role in cardiovascular diseases
Angelo Michele de Candia, Diane Xavier de Ávila, Gustavo Rodolfo Moreira, et al.
American Heart Journal Plus Cardiology Research and Practice (2021) Vol. 9, pp. 100046-100046
Open Access | Times Cited: 34
Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial Fibrillation
Abhinav Sharma, Ziad Hijazi, Ulrika Andersson, et al.
Circulation (2018) Vol. 138, Iss. 16, pp. 1666-1676
Open Access | Times Cited: 41
Clinical and Biomarker Predictors of Expanded Heart Failure Outcomes in Patients With Type 2 Diabetes Mellitus After a Recent Acute Coronary Syndrome: Insights From the EXAMINE Trial
Abhinav Sharma, Muthiah Vaduganathan, João Pedro Ferreira, et al.
Journal of the American Heart Association (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 39
Cytokines in heart failure
A Stanciu
Advances in clinical chemistry (2019), pp. 63-113
Closed Access | Times Cited: 37
Reappraisal of Inflammatory Biomarkers in Heart Failure
Thanat Chaikijurajai, W.H. Wilson Tang
Current Heart Failure Reports (2020) Vol. 17, Iss. 1, pp. 9-19
Open Access | Times Cited: 36
Distinct Pathological Pathways in Patients With Heart Failure and Diabetes
Jasper Tromp, Adriaan A. Voors, Abhinav Sharma, et al.
JACC Heart Failure (2020) Vol. 8, Iss. 3, pp. 234-242
Open Access | Times Cited: 35
Growth Differentiation Factor-15 (GDF-15) is a Biological Marker in Heart Failure
Amina M. Alieva, Е. В. Резник, Т. В. Пинчук, et al.
The Russian Archives of Internal Medicine (2023) Vol. 13, Iss. 1, pp. 14-23
Open Access | Times Cited: 11
Cardiac Cachexia
Elissa Driggin, Kevin J. Clerkin
JACC Heart Failure (2025) Vol. 13, Iss. 2, pp. 330-331
Closed Access
Page 1 - Next Page

Scroll to top